Quoin Pharmaceuticals, Ltd.
SEC Filing List
QNRX CIK: 0001671502
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| DEF 14A | Definitive proxy statements | Quoin Pharmaceuticals Ltd. | Toppan Merrill/FA | 10/02/2026 | |
| 424B3 | Prospectus filed pursuant to Rule 424(b)(3) | Quoin Pharmaceuticals Ltd. | Toppan Merrill/FA | 09/25/2026 | |
| EFFECT | Effectiveness refer to a Registration St... | cik 9999999995 /fa | 09/25/2026 | ||
| PRE 14A | Preliminary proxy statement not related ... | Quoin Pharmaceuticals Ltd. | Toppan Merrill/FA | 09/22/2026 | |
| 8-K | Current report filing | Quoin Pharmaceuticals Ltd. | Toppan Merrill/FA | 09/22/2026 | |
| S-3 | Registration statement for specified tra... | Quoin Pharmaceuticals Ltd. | Toppan Merrill/FA | 09/18/2026 | |
| D | Official notice of an offering of securi... | Toppan Merrill/FA | 09/10/2026 | ||
| 8-K | Current report filing | Quoin Pharmaceuticals Ltd. | Toppan Merrill/FA | 09/10/2026 | |
| 4 | Statement of changes in beneficial owner... | Carter Denise P. | Toppan Merrill/FA | 09/01/2026 | |
| 4 | Statement of changes in beneficial owner... | Myers Michael | Toppan Merrill/FA | 09/01/2026 | |
| No record found. | |||||
| Load More | |||||
